# NEX-I: Research, Worcester, United States

> NEX-I: NEX-I isn't just another biotech firm, it's the future. Based in Worcester, United States. Founded 2021.

Source: https://millionrounds.com/startup/nex-i-2 (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# NEX-I

NEX-I isn't just another biotech firm, it's the future.

Funding reported Last round: Series A

Research Worcester, United States

Company summary

- **Founded:** 2021 5 years old
- **Team:** 10 1 to 10 people
- **Funding reported:** $26B in dollars
- **Last round:** Series A Oct 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for NEX-I has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About NEX-I

NEX-I isn't just another biotech firm, it's the future.

We're pioneering a transformative shift in cancer immunotherapy, unveiling robust solutions – start with our 1st episode, ONCOKINE®. While conventional treatments often face resistance from evolving cancer cells, our groundbreaking platform identifies and counters this challenge. By understanding the mechanisms of refractory cancers and targeting ONCOKINE®, NEX-I sets a new standard. We're redefining the battle against cancer by actively inhibiting cancer cell growth and putting an end to metastasis. Experience the next era of cancer therapy with NEX-I.

## What company datasets say NEX-I raised

Funding, as reported

Reported in all **$26B** in dollars

Rounds **2**

Last round **Series A**

Last round size **$73M**

Last round date **Oct 2022**

Investors listed **11**

## On a portfolio page

Investors who name them

- [Atinum Investment](https://millionrounds.com/fund/atinum-investment)

Each firm lists NEX-I on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

biotechnology research research services

Built with from their website

Google Maps NAVER Viewport Meta Google Font API Microsoft Exchange Microsoft 365 Apps & Services Mobile Friendly Open Graph jQuery Lua

+8 more

Swiper Google Maps (Non Paid Users) Naver Analytics Microsoft Office Microsoft Exchange Online OpenResty VueJS Nginx

- **Sector:** Research
- **Region:** Massachusetts
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/nex-eye)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put NEX-I in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)